4-Bromoacetamidoprocaine: An affinity ligand for brain muscarinic and nicotinic cholinergic receptors

@article{Saraswati20044BromoacetamidoprocaineAA,
  title={4-Bromoacetamidoprocaine: An affinity ligand for brain muscarinic and nicotinic cholinergic receptors},
  author={Manda Saraswati and Mazzaz Hashmi and Leo G. Abood},
  journal={Neurochemical Research},
  year={2004},
  volume={17},
  pages={247-252}
}
This study describes the synthesis, receptor binding characteristics, and some behavioral effects of p-bromoacetamidoprocaine (BAP), a new affinity ligand for brain muscarinic and nicotinic cholinergic receptors. The reversible binding of [3H]QNB to rat brain membranes was inhibited in a concentration dependent and saturable manner by both procaine and BAP, with Ki values of 4×10−6 and 3×10−7 M, respectively, and complete inhibition at 1×10−5 M. Both procaine and BAP, although at much… 

A Potential Cholinergic Mechanism of Procaine's Limbic Activation*

The local anesthetic procaine, when administered to humans intravenously (i.v.), yields brief intense emotional and sensory experiences, and concomitant increases in anterior paralimbic cerebral

References

SHOWING 1-10 OF 17 REFERENCES

[3H]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues.

[3H]methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors.

Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics.

Analysis of the effects of local anesthetics in terms of an allosteric model of drug action showed that they bind to inactive states of sodium channels with at least a 10-fold higher affinity than active states.

Procaine isothiocyanate: An irreversible inhibitor of the specific binding of [3H]batrachotoxinin-A benzoate to sodium channels

Protection studies with procaine and other local anesthetics suggest that only the 68 kDa species was related to local anesthetic binding, which is greatly accelerated in a concentration dependent manner in the presence of PRIT.

14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.

The binding properties of 14 beta-(bromoacetamido)morphine (BAM) and the ability of BAM to irreversibly inhibit opioid binding to rat brain membranes were examined to characterize the affinity and

Interaction of 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride, ryanodine and procaine with muscarinic cholinergic M2 receptor sites in smooth muscle.

The results suggest that TMB-8 and procaine, and possibly other drugs, may interact directly with the muscarinic cholinergic M2 receptor sites in a competitive manner.

Photoaffinity labeling of the acetylcholine binding sites on the nicotinic receptor by an aryldiazonium derivative.

DDF behaves as a monovalent photoaffinity label of the acetylcholine-binding site, which helps to fully block alpha-bungarotoxin binding to the membrane-bound receptor.

The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.

Biochemical and patch-clamp results suggested that, at the nicotinic receptors of the neuromuscular junction, mecamylamine acted as a noncompetitive blocker, binding primarily to the receptor's open channel conformation.

Procaine rapidly inactivates acetylcholine receptors from Torpedo and competes with agonist for inhibition sites.

The data support a mechanism where procaine binds preferentially to the open-channel AChR state, since no procaine-induced inactivation is observed without agonist and kr's dependence on [ACh] in the channel-activating range closely parallels that of 86Rb+ flux response to ACh.